Managing vancomycin-resistant enterococci. A winning team approach.
Antibiotics have been the treatment of choice for a broad range of bacterial infections for decades. In recent years, however, concern has been growing over the increasing incidence of infections that are resistant to known antibiotics. A 1995 outbreak of ampicillin- and vancomycin-resistant enterococci (VRE) at the 3Y site of the McMaster University Medical Centre brought this concern home to us and resulted in the development of outbreak-management guidelines for VRE.
Robinson
K
K
Chedoke-McMaster Hospitals.
Duff
Z
Z
Mercer
J
J
Cran
M
M
Gill-Morton
P
P
Main
S
S
D000668:Ampicillin Resistance; D000900:Anti-Bacterial Agents; D003428:Cross Infection / Q000517:prevention & control*; D004196:Disease Outbreaks; D004352:Drug Resistance, Microbial; D016983:Enterococcus; D016908:Gram-Positive Bacterial Infections / Q000517:prevention & control*; D006801:Humans; D017053:Infection Control / Q000379:methods*; D010348:Patient Care Team; D014640:Vancomycin
D000900:Anti-Bacterial Agents; D014640:Vancomycin